To access this element change to forms mode OFF
Grant Award View - GA30251
Uterine-Targeted Delivery of Dual Action Therapy for Preventing Preterm...
GA ID:
GA30251
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$461,472.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Uterine-Targeted Delivery of Dual Action Therapy for Preventing Preterm Birth
Purpose:
Progesterone is currently a leading therapy for preventing preterm birth. Unfortunately, many women are insensitive to the relaxatory effects of progesterone. We discovered a dual-action agent that (1) maintains uterine progesterone receptor expression in a state that is consistent with progesterone sensitivity, and (2) directly inhibits uterine contractions. This agent has potential to increase the percentage of women that respond to progesterone, while exerting 'dual action' as a tocolytic.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162684
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA